Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
Merck
US Department of Justice
Moodys
Federal Trade Commission
Boehringer Ingelheim
Accenture
Baxter

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076157

« Back to Dashboard

NDA 076157 describes CLONIDINE, which is a drug marketed by Actavis Labs Ut Inc, Aveva, Mayne Pharma, Mylan Technologies, Tris Pharma Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, X-gen Pharms Inc, Zydus Pharms Usa Inc, Actavis Elizabeth, Ajanta Pharma Ltd, Amneal Pharms Ny, Anchen Pharms, Jubilant Generics, Lupin Ltd, Mayne Pharma Inc, Xiamen Lp Pharm Co, Alembic Pharms Ltd, Am Therap, Aurolife Pharma Llc, Chartwell Molecules, Duramed Pharms Barr, Frontida Biopharm, Impax Labs, Interpharm, Mylan, Par Pharm, Prinston Inc, Sun Pharm Inds Inc, Teva, Unichem, Warner Chilcott, Watson Labs, and Yung Shin Pharm, and is included in sixty-three NDAs. It is available from five suppliers. Additional details are available on the CLONIDINE profile page.

The generic ingredient in CLONIDINE is chlorthalidone; clonidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.
Summary for 076157
Tradename:CLONIDINE
Applicant:Aveva
Ingredient:clonidine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 076157
Mechanism of ActionAdrenergic alpha2-Agonists
Medical Subject Heading (MeSH) Categories for 076157
Suppliers and Packaging for NDA: 076157
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 076157 ANDA Physicians Total Care, Inc. 54868-6214 E 54868-6214-0
CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 076157 ANDA Physicians Total Care, Inc. 54868-6260 E 54868-6260-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.1MG/24HR
Approval Date:Aug 18, 2009TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.2MG/24HR
Approval Date:Aug 18, 2009TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.3MG/24HR
Approval Date:Aug 18, 2009TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
UBS
Deloitte
Cantor Fitzgerald
Mallinckrodt
Citi
Express Scripts
Cerilliant
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.